SCHERING-PLOUGH CORPORATION Underwriting AgreementUnderwriting Agreement • September 17th, 2007 • Schering Plough Corp • Pharmaceutical preparations • New York
Contract Type FiledSeptember 17th, 2007 Company Industry JurisdictionSchering-Plough Corporation, a New Jersey corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”), for whom you are acting as representatives, (the “Representatives”) an aggregate of $1,000,000,000 principal amount of the 6.00% Senior Notes due 2017 (the “2017 Notes”) and $1,000,000,000 principal amount of the 6.55% Senior Notes due 2037 specified above (the “2037 Notes” and, together with the 2017 Notes, the “Securities”). The proceeds from the sale of the Securities are intended to be used to fund a portion of the purchase price for the Company’s planned acquisition of Organon BioSciences N.V., a Netherlands company (“Organon BioSciences”) pursuant to a Letter of Offer, dated March 12, 2007, between the Company and Akzo Nobel N.V., or, if the acquisition is not completed, for general corporate purposes.